The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HAEMATOLOGY
Volume 98, Issue 4, Pages 393-397
Publisher
Wiley
Online
2016-12-25
DOI
10.1111/ejh.12844
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation
- (2016) Victoria Jacobs et al. AMERICAN JOURNAL OF CARDIOLOGY
- Antithrombotic Therapy for VTE Disease
- (2016) Clive Kearon et al. CHEST
- Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation
- (2016) N. M. Intagliata et al. DIGESTIVE DISEASES AND SCIENCES
- Decreasedin vitroanticoagulant potency of Rivaroxaban and Apixaban in plasma from patients with cirrhosis
- (2015) Wilma Potze et al. HEPATOLOGY
- Safety and efficacy of pharmacological thromboprophylaxis for hospitalized patients with cirrhosis: a single-center retrospective cohort study
- (2015) J. Shatzel et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Gastrointestinal bleeding in patients receiving oral anticoagulation: Current treatment and pharmacological perspectives
- (2015) Alessandro Di Minno et al. THROMBOSIS RESEARCH
- The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis
- (2014) C. Chai-Adisaksopha et al. BLOOD
- Deep vein thrombosis and pulmonary embolism in cirrhotic patients: Systematic review
- (2014) Ashish Aggarwal WORLD JOURNAL OF GASTROENTEROLOGY
- Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor
- (2013) Dagmar Kubitza et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Anticoagulant Therapy with the Oral Direct Factor Xa Inhibitors Rivaroxaban, Apixaban and Edoxaban and the Thrombin Inhibitor Dabigatran Etexilate in Patients with Hepatic Impairment
- (2013) Jochen Graff et al. CLINICAL PHARMACOKINETICS
- Established and new-generation antithrombotic drugs in patients with cirrhosis – Possibilities and caveats
- (2013) Ton Lisman et al. JOURNAL OF HEPATOLOGY
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Anticoagulation on Patients With Cirrhosis and Portal Vein Thrombosis
- (2012) María Gabriela Delgado et al. Clinical Gastroenterology and Hepatology
- Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial
- (2012) J Donald Easton et al. LANCET NEUROLOGY
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Factors at Admission Associated With Bleeding Risk in Medical Patients
- (2010) Hervé Decousus et al. CHEST
- The international normalized ratio to prioritize patients for liver transplantation: problems and possible solutions
- (2009) A. TRIPODI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans
- (2008) N. Raghavan et al. DRUG METABOLISM AND DISPOSITION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started